Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 342 of 6351
-
New lung cancer trial combines immunotherapy and targeted radiation
Disease control Not yet recruitingThis is a randomized trial evaluating the efficacy and safety of sequential dual-agent immunotherapy and risk-adapted radiotherapy for patients with locally advanced non-small cell lung cancer (NSCLC) with a PD-L1 tumor proportion score of at least 50%. Participants will be rando…
Phase 2 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Electric zaps to the gut could tame diabetes and fatty liver
Disease control Not yet recruitingThis study is designed to evaluate the efficacy, safety, and mechanisms of pulsENDO procedure in patients with T2DM and its effect on MASLD.
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Teens to get Weight-Loss drug right after surgery in new trial
Disease control Recruiting nowThis is a Phase 3a, randomized, parallel-controlled trial designed to compare the early re-initiation of semaglutide, starting two weeks after sleeve gastrectomy, to standard care (no pharmacotherapy following surgery). The trial will involve 150 youth with severe obesity who hav…
Phase 3 • Sponsor: Children's Hospital Los Angeles • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Stem cell injection during bypass surgery aims to repair damaged hearts
Disease control Not yet recruitingThis clinical study will evaluate the safety and tolerability of HiCM-188, an investigational allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyocyte therapy, in adults with advanced heart failure who are undergoing coronary artery bypass grafting (CABG) surgery. P…
Phase 1/2 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Ethiopian surgery infection study aims to save lives and limbs
Prevention Not yet recruitingThe study examines surgical site infections and antimicrobial resistance following life-saving surgeries like C-sections and leg fracture repairs in Ethiopia. It does not include healthy volunteers because it specifically focuses on patients who require these urgent operations du…
Sponsor: Karolinska Institutet • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Spinal stimulation may steady blood pressure after spinal cord injury
Disease control Not yet recruitingThe purpose of this study is to learn whether stimulation applied to the spinal cord through the skin (called transcutaneous spinal stimulation) can help control blood pressure in people with a spinal cord injury. The main questions this study attempts to solve: 1. What are the…
Sponsor: Kessler Foundation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Home saliva tests could map Alzheimer's genetic risk across france
Knowledge-focused Recruiting nowALZEVIT is a nationwide, decentralized, digital-first cohort study in France designed to establish a large-scale Apolipoprotein E (APOE) genotyping registry and enable precision prevention strategies for Alzheimer's disease (AD). Sponsored by Firalis SA and conducted in collabora…
Sponsor: Firalis SA • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a school-based trauma program keep incarcerated teens from turning to drugs?
Disease control Not yet recruitingThis pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Experimental drug targets Hard-to-Treat neuroendocrine cancers
Disease control Not yet recruitingThis study will enroll patients with central lab confirmed NCAM (CD56 IHC) positive metastatic neuroendocrine neoplasms that have progressed after standard of care treatment. CTX-471 to be administered as an intravenous (IV) infusion at either 0.3 mg/kg or 0.6 mg/kg every 2 weeks…
Phase 2 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a tiny implant seal large artery holes faster and safer?
Disease control Not yet recruitingThe objective of this study is to establish reasonable assurance of safety and effectiveness for the xDot Access Management System (AMS) when used as indicated for femoral-arterial and femoral-venous closure. Additionally, this study will provide preliminary evidence on the impac…
Sponsor: xDot Medical, Inc • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Pacemaker signals may unmask a rare heart condition
Diagnosis Not yet recruitingThis multicenter prospective study aims to evaluate the diagnostic performance of right ventricular sensing amplitude measured during cardiac implantable electronic device (CIED) implantation (pacemaker or defibrillator) to identify cardiac amyloidosis in patients with left ventr…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Heart valve fix without the hospital stay? trial tests Same-Day discharge
Disease control Not yet recruitingTranscatheter aortic valve implantation (TAVI) has become the standard treatment for patients with severe aortic stenosis across a broad range of surgical risk. Advances in device technology and procedural techniques have enabled minimalist approaches and shorter hospital stays. …
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a detailed map of pain nerves unlock new chronic pain treatments?
Knowledge-focused Not yet recruitingThis study aims to improve our understanding of how the nerves that detect and transmit pain signals work in humans. Chronic pain affects millions of people worldwide and can be difficult to treat because the biological mechanisms underlying pain are not yet fully understood. By …
Sponsor: King's College Hospital NHS Trust • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Gut bacteria may hold key to stronger muscles in aging
Disease control Recruiting nowThe purpose of this pilot study is to evaluate whether HB05P, a health functional food ingredient containing pasteurized Akkermansia muciniphila HB05, improves muscle strength, and to evaluate its safety. This is a randomized, double-blind, placebo-controlled, parallel-group, si…
Sponsor: Pusan National University Yangsan Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a digital parenting program empower latino families?
Prevention Not yet recruitingThe objective of this study is to harness digital technology to bring to scale a culturally adapted and evidence-based parenting intervention for Latinos (Nuestras Familias: Andando Entre Culturas). The Latino Youth and Family Empowerment - III study (LYFE-III) proposed here will…
Sponsor: Texas A&M University • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
Ear acupressure: a new weapon against chemotherapy side effects?
Prevention Not yet recruitingChemotherapy-induced nausea and vomiting (CINV) remains one of the most common and distressing adverse effects in patients receiving highly emetogenic chemotherapy (HEC). Despite the widespread use of guideline-recommended triple antiemetic therapy, a substantial proportion of pa…
Sponsor: China Medical University, China • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
Which wound dressing best protects knee replacements?
Disease control Not yet recruitingThis study is a single-center, prospective, randomized, open-label clinical trial evaluating three commercially available closed-incision negative pressure wound therapy (ciNPWT) devices: NPseal, PICO, and Prevena, in adult patients undergoing primary total knee arthroplasty (TKA…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a targeted drug tame neuroendocrine tumors in everyday practice?
Disease control Not yet recruitingPrior clinical trials have demonstrated promising efficacy and manageable safety of surufatinib in neuroendocrine tumors (NETs). This real-world study aims to evaluate the clinical efficacy and safety of surufatinib in patients with NETs, providing additional real-world evidence …
Sponsor: Yefeng • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a new tracer reveal hidden tumors?
Diagnosis Not yet recruitingThe objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic Resonance Imaging (PET-MR) and Positron Emission Tomography / Computed Tomography (PET-CT) imaging of sol…
Early phase 1 • Sponsor: Lumina Pharmaceuticals Inc • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
Could a gentler breath test replace the harsh blow for COPD diagnosis?
Diagnosis Not yet recruitingAirway disease, such as chronic obstructive pulmonary disease (COPD), is usually diagnosed through breathing tests like spirometry. However, it requires people to blow forcefully into a machine several times which can be uncomfortable and difficult for some patients. This study …
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC